Abstract
Background & aims:
Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor whose activation has been linked to several physiologic pathways including those related to the regulation of intestinal inflammation. We sought to determine whether PPAR gamma could function as an endogenous anti-inflammatory pathway in a murine model of intestinal ischemia-reperfusion (I/R) injury.
Methods:
PPAR gamma-deficient and wild-type mice were examined for their response to I/R procedure. Treatment with a PPAR gamma-specific ligand was also performed.
Results:
In a murine model of intestinal I/R injury, we observed more severe injury in PPAR gamma-deficient mice and protection against local and remote tissue injury in mice treated with a PPAR gamma-activating ligand, BRL-49653. Activation of PPAR gamma resulted in down-regulation of intercellular adhesion molecule 1 expression by intestinal endothelium and tissue tumor necrosis factor alpha messenger RNA levels most likely by inhibition of the NF-kappa B pathway.
Conclusions:
These data strongly suggest that an endogenous PPAR gamma pathway exists in tissues that may be amenable to therapeutic manipulation in I/R-related injuries.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Cells, Cultured
-
Colitis / drug therapy
-
Colitis / immunology*
-
Colitis / pathology
-
Epithelial Cells / cytology
-
Epithelial Cells / enzymology
-
Gastric Mucosa / metabolism
-
Gene Expression / drug effects
-
Gene Expression / immunology
-
Hypoglycemic Agents / pharmacology
-
In Vitro Techniques
-
Intercellular Adhesion Molecule-1 / genetics
-
Interleukin-8 / genetics
-
Intestinal Mucosa / metabolism
-
Intestinal Mucosa / pathology
-
L-Lactate Dehydrogenase / analysis
-
Liver / metabolism
-
Liver / pathology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Knockout
-
NF-kappa B / metabolism
-
Peroxidase / analysis
-
Pneumonia / drug therapy
-
Pneumonia / immunology
-
Pneumonia / pathology
-
RNA, Messenger / analysis
-
Receptors, Cytoplasmic and Nuclear / immunology*
-
Receptors, Cytoplasmic and Nuclear / metabolism*
-
Reperfusion Injury / drug therapy
-
Reperfusion Injury / immunology*
-
Reperfusion Injury / pathology
-
Rosiglitazone
-
Stomach / pathology
-
Thiazoles / pharmacology
-
Thiazolidinediones*
-
Transcription Factors / immunology*
-
Transcription Factors / metabolism*
-
Tumor Necrosis Factor-alpha / genetics
Substances
-
Hypoglycemic Agents
-
Interleukin-8
-
NF-kappa B
-
RNA, Messenger
-
Receptors, Cytoplasmic and Nuclear
-
Thiazoles
-
Thiazolidinediones
-
Transcription Factors
-
Tumor Necrosis Factor-alpha
-
Rosiglitazone
-
Intercellular Adhesion Molecule-1
-
L-Lactate Dehydrogenase
-
Peroxidase